Proniras

Proniras is a clinical-stage biotechnology company advancing the clinical development of PRN-001-01 (tezampanel) as a potential treatment for opioid withdrawal and related addiction disorders. The company aims to help patients cease opioid use and maintain an opioid-free lifestyle by alleviating symptoms associated with opioid withdrawal.